Jushi Holdings (JUSHF) Cash & Current Investments (2020 - 2026)
Jushi Holdings (JUSHF) reported Cash & Current Investments of $39.7 million for Q1 2026, up 52.92% year-over-year from $26.0 million in Q1 2025, and up 65.1% quarter-over-quarter from $24.0 million in Q4 2025.
Jushi Holdings (JUSHF) Cash & Current Investments (2020 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 7 years of Cash & Current Investments data on file, last reported at $39.7 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $39.7 million, up 52.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.7 million (up 52.92% YoY), and the FY2025 annual result was $24.0 million, up 23.19% from the prior year.
- Cash & Current Investments climbed to $39.7 million in Q1 2026 per JUSHF's latest filing, from $24.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $43.2 million in Q2 2022 and troughed at $18.5 million in Q1 2023.
- A 5-year average of $27.7 million and a median of $27.3 million in 2022 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 72.41% in 2022, then surged 53.81% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $26.2 million in 2022, then advanced by 11.3% to $29.2 million in 2023, then sank by 33.04% to $19.5 million in 2024, then grew by 23.19% to $24.0 million in 2025, then jumped by 65.1% to $39.7 million in 2026.
- Business Quant data shows JUSHF's Cash & Current Investments at $39.7 million in Q1 2026, $24.0 million in Q4 2025, and $23.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 39.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.70 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 23.21 Mn |
| Mar 31, 2025 | 25.96 Mn |
| Dec 31, 2024 | 19.52 Mn |
| Sep 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 32.88 Mn |
| Mar 31, 2024 | 28.41 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.32 Mn |
| Jun 30, 2023 | 29.91 Mn |
| Mar 31, 2023 | 18.47 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 43.19 Mn |
| Dec 31, 2021 | 94.96 Mn |
| Dec 31, 2020 | 85.86 Mn |